The Lancet Respiratory Medicine, 10(1), 47-58. Elsevier Limited Menzies-Gow, A, Gurnell, M, Heaney, L G, Corren, J, Bel, E H, Maspero, J, Harrison, T, Jackson, D J, Price, D, Lugogo, N, Kreindler, J, Burden, A, de Giorgio-Miller, A, Padilla, K, Martin, U J & Garcia Gil, E 2022, ' Oral corticosteroid elimination via a personalised reduction algorithm in adults with severe, eosinophilic asthma treated with benralizumab (PONENTE) : a multicentre, open-label, single-arm study ', The Lancet Respiratory Medicine, vol. 10, no. 1, pp. 47-58 . https://doi.org/10.1016/S2213-2600(21)00352-0 Menzies-Gow, A, Gurnell, M, Heaney, L G, Corren, J, Bel, E H, Maspero, J, Harrison, T, Jackson, D J, Price, D, Lugogo, N, Kreindler, J, Burden, A, de Giorgio-Miller, A, Padilla, K, Martin, U J & Garcia Gil, E 2022, ' Oral corticosteroid elimination via a personalised reduction algorithm in adults with severe, eosinophilic asthma treated with benralizumab (PONENTE): a multicentre, open-label, single-arm study ', The Lancet. Respiratory medicine, vol. 10, no. 1, pp. 47-58 . https://doi.org/10.1016/S2213-2600(21)00352-0